↓ Skip to main content

Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer

Overview of attention for article published in Cancer Immunology, Immunotherapy, July 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
patent
2 patents

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
52 Mendeley
Title
Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer
Published in
Cancer Immunology, Immunotherapy, July 2013
DOI 10.1007/s00262-013-1448-0
Pubmed ID
Authors

James L. Gulley, Christopher R. Heery, Ravi A. Madan, Beatriz A. Walter, Maria J. Merino, William L. Dahut, Kwong-Yok Tsang, Jeffrey Schlom, Peter A. Pinto

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 19%
Student > Ph. D. Student 10 19%
Researcher 6 12%
Student > Doctoral Student 5 10%
Student > Bachelor 3 6%
Other 10 19%
Unknown 8 15%
Readers by discipline Count As %
Medicine and Dentistry 23 44%
Agricultural and Biological Sciences 4 8%
Biochemistry, Genetics and Molecular Biology 3 6%
Nursing and Health Professions 3 6%
Computer Science 3 6%
Other 4 8%
Unknown 12 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2023.
All research outputs
#7,168,149
of 23,394,907 outputs
Outputs from Cancer Immunology, Immunotherapy
#965
of 2,929 outputs
Outputs of similar age
#59,782
of 195,749 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#12
of 19 outputs
Altmetric has tracked 23,394,907 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 2,929 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,749 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.